tRNAGlyGCC-Derived Internal Fragment (i-tRF-GlyGCC) in Ovarian Cancer Treatment Outcome and Progression.
Cancers (Basel)
2021
14
1
Prediction of adverse perinatal outcome and the mean time until delivery in twin pregnancies with suspected pre-eclampsia using sFlt-1/PIGF ratio.
Pregnancy Hypertens
2021
24
37-43
Fetal cerebral blood-flow redistribution: analysis of Doppler reference charts and association of different thresholds with adverse perinatal outcome.
Ultrasound Obstet Gynecol
2021
58
5
705-715
Non-collagenous extracellular matrix protein dermatopontin may play a role as another component of transforming growth factor-β signaling pathway in colon carcinogenesis.
Majallah-iulum-i payah-i pizishki-i Iran = Iranian journal of basic medical sci
2021
24
4
444-450
Challenges and Opportunities for Real-World Evidence in Metastatic Luminal Breast Cancer.
Breast Care (Basel)
2021
16
2
108-114
Detection of maternal and fetal stress from the electrocardiogram with self-supervised representation learning.
Sci Rep
2021
11
1
The prognostic and diagnostic potential of kallikrein-related peptidases in ovarian cancer.
Expert Rev Mol Diagn
2021
21
6
535-545
Retrospective Study of Radiotherapy Impact on the Outcome of Material-assisted Implant-based Subpectoral Breast Reconstruction.
Anticancer Res
2021
41
4
2017-2024
Characterization of long-term responders following treatment with talazoparib (TALA) or physician's choice of chemotherapy (PCT) in the phase 3 embraca trial.
J Clin Oncol
2021
39 Suppl S
15
Clinical outcomes in patients (pts) with a history of central nervous system (CNS) metastases receiving talazoparib (TALA) or physician's choice of chemotherapy (PCT) in the phase 3 EMBRACA trial.
J Clin Oncol
2021
39 Suppl S
15